Am J Clin Oncol 1993, 16: 256–263.CrossRefPubMed 7. Wright J, Jones G, Whelan T: find protocol Patient preference for high or low dose rate brachytherapy in carcinoma of the cervix. Radiother Oncol 1994, 33: 187–194.CrossRefPubMed 8. Akine Y, Arimoto H, Ogino T, Kajiura Y, Tsukiyama I, Egawa S: High-dose-rate intracavitary irradiation in the treatment of carcinoma of Selonsertib cost the uterine cervix: early experience with 84 patients. Int J Radiat Oncol Biol Phys 1988, 14: 893–8.CrossRefPubMed

9. Arai T, Nakano T, Morita S, Sakashita K, Nakamura YK, Fukuhisa K: High-dose-rate remote afterloading intracavitary radiation therapy for cancer of the uterine cervix. Cancer 1992, 69: 175–80.CrossRefPubMed 10. Clark BG, Souhami L, Roman TN, Chappell R, Evans MD, Fowler JF: The prediction of late rectal complications in patients treated with high dose-rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys 1997, 38: 989–93.CrossRefPubMed 11. Glaser FH: Comparison of HDR afterloading with 192Ir versus conventional radium therapy in cervix cancer: 5-year results and complications. Sonderb Strahlenther Onkol 1988, 82: 106–13.PubMed 12. Kapp KS, Stuecklschweiger GF, Kapp DS, Poschauko J, Pickel H, Hackl A: Carcinoma of the cervix: analysis of complications after primary

external beam radiation and Ir-192 HDR brachytherapy. Radiother Oncol 1997, 42: 143–53.CrossRefPubMed 13. Sarkaria JN, Petereit DG, Stitt JA, Hartman T, Chappell R, Thomadsen BR: A comparison of the

efficacy and complication rates of low dose-rate Tucidinostat ic50 versus high dose-rate brachytherapy Cyclin-dependent kinase 3 in the treatment of uterine cervical carcinoma. Int J Radiat Oncol Biol Phys 1994, 30: 75–82. discussion, 247PubMed 14. Vahrson H, Romer G: 5-year results with HDR afterloading in cervix cancer: dependence on fractionation and dose. Sonderb Strahlenther Onkol 1988, 82: 139–46.PubMed 15. Stewart AJ, Viswanathan AN: Current controversies inhigh-dose-rate versus low-dose-rate brachytherapy for cervicalcancer. Cancer 2006, 1; 107 (5) : 908–15.CrossRef 16. Mantel N, Haenszel W: Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959, 22: 719–748.PubMed 17. DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials 1986, 7: 177–188.CrossRefPubMed 18. Higgins JPT, Thompson SG, Deeks JJ, Altman DG: Measuring inconsistency in meta-analysis. BMJ 2003, 327: 557–560.CrossRefPubMed 19. Higgins JPT, Green S, Eds: Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]. The Cochrane Collaboration; 2008. 20. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Schunemann hj: rating quality of evidence and strength of recommendations: grade: what is “”quality of evidence”" and why is it important to clinicians? BMJ 2008, 336 (7651) : 995–998.CrossRefPubMed 21.